Elderly show similar antibody response to first dose of AstraZeneca, Pfizer Covid-19 shots: UK study
The first study to directly compare immune reactions between Pfizer’s and AstraZeneca’s Covid-19 vaccines found strong and broadly similar antibody responses in over-80-year-olds after a first dose of either shot, scientists said on April 14.